ロード中...
Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a Meta-analysis
AIM: To systematically compare the efficacy and safety of off-label bevacizumab versus licensed ranibizumab intravitreal injections as well as monthly regimen versus pro re nata [PRN (as needed)] regimen in the treatment of neovascular age-related macular degeneration (nAMD). METHODS: Relevant publi...
保存先:
| 出版年: | Int J Ophthalmol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Journal of Ophthalmology Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4325258/ https://ncbi.nlm.nih.gov/pubmed/25709924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2015.01.26 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|